WT
REGN icon

Washington Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Washington Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-38
Closed -$24.1K – 603
2025
Q1 		$24.1K Sell
38
-2
-5% -$1.38K ﹤0.01% 501
2024
Q4 		$28.5K Sell
40
-300
-88% -$252K ﹤0.01% 526
2024
Q3 		$357K Sell
340
-2
-0.6% -$2.23K 0.01% 230
2024
Q2 		$359K Hold
342
– – 0.01% 229
2024
Q1 		$329K Hold
342
– – 0.01% 233
2023
Q4 		$300K Buy
342
+2
+0.6% +$1.65K 0.01% 235
2023
Q3 		$280K Buy
340
+1
+0.3% +$786 0.01% 218
2023
Q2 		$244K Buy
339
+2
+0.6% +$1.54K 0.01% 237
2023
Q1 		$277K Hold
337
– – 0.01% 228
2022
Q4 		$243K Sell
337
-1
-0.3% -$738 0.01% 233
2022
Q3 		$233K Hold
338
– – 0.01% 224
2022
Q2 		$200K Hold
338
– – 0.01% 246
2022
Q1 		$236K Buy
338
+300
+789% +$190K 0.01% 244
2021
Q4 		$24K Sell
38
-34,297
-100% -$21.1M ﹤0.01% 552
2021
Q3 		$20.8M Buy
34,335
+772
+2% +$479K 0.59% 47
2021
Q2 		$18.7M Buy
33,563
+1,423
+4% +$721K 0.53% 58
2021
Q1 		$15.2M Buy
32,140
+6,097
+23% +$2.97M 0.47% 72
2020
Q4 		$12.6M Buy
26,043
+952
+4% +$514K 0.41% 82
2020
Q3 		$14M Sell
25,091
-590
-2% -$358K 0.52% 65
2020
Q2 		$16M Sell
25,681
-5,021
-16% -$2.85M 0.67% 39
2020
Q1 		$15M Buy
30,702
+1,203
+4% +$496K 0.71% 37
2019
Q4 		$11.1M Buy
+29,499
New +$9.92M 0.44% 80
2018
Q3 		– Sell
-231
Closed -$80K – 667
2018
Q2 		$80K Buy
+231
New +$72.2K ﹤0.01% 347

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Washington Trust's REGN Position: Q2 2025 in Review

Washington Trust sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 38 shares — an estimated $24.1K sold.

Washington Trust first reported a position in REGN in Q2 2018 and held it in 23 quarters. The position peaked at $20.8M in Q3 2021. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Washington Trust reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Washington Trust sold 38 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $24.1K.
  • Washington Trust first reported a position in Regeneron Pharmaceuticals in Q2 2018 and held it in 23 quarters.
  • Washington Trust's Regeneron Pharmaceuticals position peaked at $20.8M in Q3 2021.
  • 1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Washington Trust's 13F filing for Q2 2025, filed 8 Aug 2025.